(Received for publication April 24, 1972) A new memberof the anthracycline group of antibiotics named requinomycin has been isolated from a strain of Streptomyces filamentosus which had been screened for anti-phage activity.
The antibiotic was obtained as yellow crystals, whose molecular formula was assigned to C40H54N2O16. It inhibits the reproduction of phage f2 in E.coli S-26, the transfer of R-factors between E. coli strains, the growth of Gram-positive bacteria and the growth in vitro of Yoshida rat sarcoma cells. Requinomycin resembles aklavin but they are apparently different in antibiotic activity against E. coli B and stability to acid hydrolysis.
The emergence and rapid spread of drug-resistant bacteria are serious problems in clinics. The drug-resistance of Gram-negative bacteria is transferred from resistant organisms to sensitive ones by recombination1*2). In this process an episome, called R-factor, which carries genetic information for several drug-inactivating enzymes, is passed on through a hair-like structure, an R-pilus. This process resembles an early step of phage f2 infection in that genetic meterial is introduced into a recipient cell through a similar structure of either R or F pilus. Based on this notion, we proposed a working hypothesis that anti-phage compoundscould inhibit R-factor transfer. From a culture broth which had been screened for anti-phage activity, an active material inhibiting R-factor transfer was isolated. It proved to be a new antibiotic and was named requinomycin. We describe in the present paper the isolation procedures and the properties of requinomycin.
Results and Discussion
Requinomycin-Producing Strain
The requinomycin-producing strain was isolated from a soil sample collected at Ojiya city, Niigata Prefecture, in 1969 and designated as MC521-C5 in our institute. Its morphological and physiological properties are listed in 0.25% NaCl, 0.32% CaCO3, 0.0005% CuSO4.5H2O, 0.0005% MnCl2-4H2O, 0.0005% ZnSO4-7H2Oin water, and the pH was adjusted to 7.4. Small pieces of a mycelial mat were withdrawn from a slant culture, inoculated into a Sakaguchi flask containing 125ml of medium C and incubated at 27°C with reciprocal shaking (seed culture). After 2 days of incubation, about 1ml portions of the seed culture were transferred to 22 flasks each containing 125ml of medium C and incubated in the same manner. After 7 days of incubation, as muchas 100mcg/mlof requinomycin was accumulated, when the pH was 8.0. Requinomycin could be determined by measuring the antibiotic titer against Bacillus subtilis by the paper disc method.
The following is an example of an isolation procedure.
To 5 liters of 7-daycultured broth, 50g Hyflo Supercel was added and the suspension was filtered. The filter cake, after washing with a small volumeof water, was mixed with 500mlof methanol and was filtered. The methanol extract was dried in vacuo at a temperature below 40°C and the residue was dissolved in 300ml of water, pH 8.0, and combined with the filtrate and the water wash. The combined solution was extracted with an equal volume of ethyl acetate at pH 8.0. The ethyl acetate layer was separated and concentrated to dryness (42 % yield). The residue was dissolved in 300ml of methanol. volume), (3) 1,500 ml of benzene-methanol (9 : 1, in volume), and (4) 500ml of benzenemethanol (1 :1, in volume) was conducted. Most of the requinomycin was found in the eluate of (4), from which the solvents were removed by evaporation in vacua and 66mg of reddish yellow powder (89% purity, 40 % overall yield) were obtained.
The powder was dissolved in a minimumamount of ethanol at 60°C and left standing at roomtemperature to obtain requinomycincrystals which were collected by nitration. The filtrate was further concentrated and left standing to obtain additional crystals. After repeting these procedures, 37mg of yellow crystals of pure requinomycin were obtained. The overall vield of requinomvcin was 15 %. Requinomycinshowedreasonable proton magnetic resonance spectral data for the empirical formula. The PMRspectrum in deuterodimethylsulfoxide, the ultraviolet and visible light absorption spectra and the infrared absorption spectrum in KBr tablet are shown in Figs. 1, 2 acid-water (25:75:900, pH 1.8) at 3,300 volts for 20 minutes, requinomycin moved to the cathode with an Rmof 0.5 (L-alanine; 1.0). A quinoid structure in the requinomycin molecule was suggested because of its positive magnesium acetate reaction3) and its infrared absorption peaks at 1580, 1633 and 1670cm"1. The ultraviolet absorption spectrum at a neutral dH resembles that of aklavinV> suggesting a similarity in the structure of their chromophore moieties, however, these antibiotics differ in stability to acid hydrolysis and in antibiotic activity against E. coli B. Based on physical and chemical properties, requinomycin is considered to be a new member of the family of anthracycline antibiotics.
Biological Properties
Requinomycin is active against Gram-positive bacteria, as shown in Table 2 . Requinomycin inhibited the growth in vitro of Yoshida rat sarcoma and incubation was continued another 90 minutes. After termination by chilling, each mixture was appropriately diluted with 0. 85% NaCl -2mM CaCl2 and 0.1ml of the diluted suspension was submitted to plaque counting using E. coli S-26 as an indicator strain. 600mp, 0.9 ml aliquots were transferred from each culture to an Erlenmyer flask (30ml vol.) which had contained 0.2ml of requinomycin solution (0. 85 % NaCl solution for a control run). After gentle mixing for 60 minutes at 37°C, the mixture was chilled, appropriately diluted with 0.85 % NaCl solution and 0. 1 ml portions of the diluted cell suspension were submitted to colony counting for determination of the numbers of total viable cells and R+ recipient cells (recipient cells which acquired the drug-resistance).
By the pour plate method, the former was counted on nutrient agar plates while the latter on minimal agar plates supplemented with 70mcg/ml of kanamycin sulfate.
cells6) by 91 %, 78% and ll % at 2mcg/ml, 0.2mcg/ml and 0.02mcg/ml, respectively.
Upon intravenous injection of requinomycin, mice died after 2 days and 9 days of injection at the doses of 2mg and 1mg per mouse, respectively, while the mouse which had received 0.5mg of requinomycin survived.
As shown in Fig. 4 , requinomycin inhibited the reproduction of phage f2 in E. colt S-26. A separate experiment demonstrated that the growth of the host strain was not inhibited by requinomycin at 100 mcg/ml.
Transfer of R-factors between E. colt strains was specifically inhibited by requinomycin under conditions where neither the growth of the donor nor the recipient strain was significantly inhibited, as shown in Fig. 5 . As described above, requinomycin which had originally been selected for its antiphage activity inhibits R-factor transfer, in support of our working hypothesis. It is unlikely that all anthracycline antibiotics are specific inhibitors of R-factor transfer.
Wehave tested several which were inactive. The detailed modeof action of requinomycin concerning anti-phage activity and inhibition of R-factor transfer will be dealt with in a forthcoming paper. AH 272a2 and AH 272&/U.S.P.
3,592,925, July 13, 1971, American Gyanaid Co., exhibit some similarity to requinomycin. However, neither was identical with requinomycin based on comparison of analytical data and IR spectra.
